LONDON: Britons aged 18 to 29 will be offered an alternative to the Oxford-AstraZeneca vaccine amid concerns over its possible link with reported rare cases of blood clots, the British government’s vaccination advisory body said on Wednesday (Thursday in Manila).

The announcement by the Joint Committee on Vaccination and Immunization (JCVI) follows a review of the Oxford jab by the Medicines and Healthcare products Regulatory Agency (MHRA).

Premium + Digital Edition

Ad-free access


P 80 per month
(billed annually at P 960)
  • Unlimited ad-free access to website articles
  • Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)

TRY FREE FOR 14 DAYS
See details
See details